Showing results (11-20 of 260) with videos related to
Sort By:
Pageof 26
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 10, 2013
Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted MeasureBrandon Aden, Bohdan Nosyk, Eve Wittenberg, et al.Tropical Medicine & International Health : TM & IH|December 7, 2019
Spatial distribution and characteristics of HIV clusters in EthiopiaRoger Ying, Lelisa Fekadu, Bruce R Schackman, et al.Archives of Pediatrics & Adolescent Medicine|September 8, 2004
The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national surveyRosalind Brannigan, Bruce R Schackman, Mathea Falco, et al.Journal of Child & Adolescent Substance Abuse|March 9, 2010
An In-Depth Survey of the Screening and Assessment Practices of Highly Regarded Adolescent Substance Abuse Treatment ProgramsJeremy Gans, Mathea Falco, Bruce R Schackman, et al.Journal of the American Geriatrics Society|November 8, 2006
Can hip protector use cost-effectively prevent fractures in community-dwelling geriatric populations?Lisa A Honkanen, Alvin I Mushlin, Mark Lachs, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2017
State Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting AntiviralsShashi N Kapadia, Philip J Jeng, Bruce R Schackman, et al.Cancer|June 12, 2009
Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancerHeather Taffet Gold, Michael J Hall, Victoria Blinder, et al.Journal of Substance Use and Addiction Treatment|June 11, 2023
Economic benefits of substance use disorder treatment: A systematic literature review of economic evaluation studies from 2003 to 2021Erminia Fardone, Iván D Montoya, Bruce R Schackman, et al.Medical Care|March 25, 2020
State Policies for Prescription Drug Monitoring Programs and Adverse Opioid-related Hospital EventsKatherine Wen, Phyllis Johnson, Philip J Jeng, et al.Journal of Substance Abuse Treatment|August 25, 2019
Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?Angélica Meinhofer, Arthur Robin Williams, Phyllis Johnson, et al.Pageof 26